Reports on the customer response to the wholesale international equities fund of Orbis Investment Management Ltd. in Australia. Attraction of the fund for refundable reserve fee; Basis of the management fees; Details of the Orbis Global Equity fund.EBSCO_bspMoney Management...
Orbis Institutional Optimal (US$) Fund c/o Orbis Investment Management Limited, Orbis House, Hamilton, HM 11, BM 2021-05-06 Entities in the same postal code Entity NameBusiness AddressRegistration Integrity Re III Ltd. Clarendon House, 2 Church Street, Pembroke, Hamilton, HM 11, BM 2025-01...
Orbis Institutional Optimal (US$) Fund c/o Orbis Investment Management Limited, Orbis House, Hamilton, HM 11, BM 2021-05-06 Entities in the same postal code Entity NameBusiness AddressRegistration Integrity Re III Ltd. Clarendon House, 2 Church Street, Pembroke, Hamilton, HM 11, BM 2025-01...
Galapagos Co., Ltd. announced that it has received ¥1.111 billion in funding from a group of investors 23-11-05 CI Pola Orbis Holdings Inc. Provides Consolidated Earnings Guidance for the Fiscal Year Ending December 31, 2023 23-10-30 CI Pola Orbis Holdings'...
上海和誉生物医药科技有限公司(Abbisko Therapeutics Co., Ltd.)是一家创立于中国上海张江,着眼全球的创新药研发公司。公司的创始人和管理团队拥有多年国际和国内大型药企的研发和管理经验,并参与了多个临床及上市新药的研发。和誉医药专注于肿瘤新药研发,以小分子肿瘤靶向和肿瘤免疫药物为核心,着眼病患及医药市场的需求...